BELITE BIO, INC (BLTE) Form 10-Q Quarterly Reports
BELITE BIO, INC (BLTE) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BLTE
CIK: 1889109
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerShang-Chih Lin
Audit LocationTaipei, Taiwan
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-05 | 2026-10-01 | 4 | 0001193125-26-414643 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001968582-26-001037 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | 4 | 0001193125-26-386794 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | 4 | 0001193125-26-386790 | View SEC Doc Filr Page |
| 6-K | 2026-09-08 | 2026-09-08 | FORM 6-K | 0001104659-26-105608 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | 4 | 0001193125-26-350218 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | 4 | 0001193125-26-350217 | View SEC Doc Filr Page |
| 6-K | 2026-08-13 | 2026-08-12 | FORM 6-K | 0001104659-26-095218 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001968582-26-000825 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001968582-26-000824 | View SEC Doc Filr Page |
| 6-K | 2026-08-11 | 2026-08-11 | FORM 6-K | 0001104659-26-094040 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001193125-26-276615 | View SEC Doc Filr Page |
| 144 | 2026-06-18 | — | 144 Filing | 0001968582-26-000631 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 | 0001193125-26-273321 | View SEC Doc Filr Page |
| 144 | 2026-06-16 | — | 144 Filing | 0001968582-26-000623 | View SEC Doc Filr Page |
| 6-K | 2026-06-15 | 2026-06-12 | FORM 6-K | 0001104659-26-073668 | View SEC Doc Filr Page |
| 6-K | 2026-05-20 | 2026-05-20 | FORM 6-K | 0001104659-26-064049 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-223925 | View SEC Doc Filr Page |
| 4 | 2026-05-08 | 2026-05-07 | 4 | 0001193125-26-214820 | View SEC Doc Filr Page |
| 4 | 2026-05-07 | 2026-05-06 | 4 | 0001193125-26-211974 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-05-05 | 4 | 0001193125-26-209004 | View SEC Doc Filr Page |
| 4 | 2026-05-05 | 2026-05-04 | 4 | 0001193125-26-206456 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | 4 | 0001193125-26-204021 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-04-30 | 4 | 0001193125-26-201466 | View SEC Doc Filr Page |
| 4 | 2026-04-30 | 2026-04-29 | 4 | 0001193125-26-197320 | View SEC Doc Filr Page |